Ask Warren

Aprogen

007460 · KOSPI · ₩007460 · 에이프로젠

₩1,870▼ ₩27 (1.42%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩36B₩36B₩32B₩36B₩24B₩27B₩40B₩37B
Cost of sales₩27B₩26B₩24B₩24B₩18B₩18B₩31B₩28B
Gross profit₩9B₩9.9B₩7.1B₩11B₩6.2B₩8.9B₩8.6B₩8.5B
Operating income−₩22B−₩21B−₩27B−₩22B−₩24B−₩22B−₩29B−₩22B
Net income−₩14B−₩28B−₩107B₩8.5B−₩12B−₩30B−₩78B−₩3.2B
Net income to shareholders−₩26B−₩18B−₩18B−₩22B−₩15B−₩15B₩1.5B−₩27B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩674B₩697B₩717B₩812B₩808B₩673B₩610B₩620B
Current assets₩163B₩167B₩179B₩248B₩252B₩132B₩134B₩162B
Cash and equivalents₩38B₩35B₩45B₩99B₩134B₩40B₩37B₩43B
Total liabilities₩260B₩266B₩259B₩324B₩310B₩257B₩170B₩177B
Current liabilities₩195B₩197B₩184B₩250B₩246B₩198B₩113B₩119B
Borrowings₩180B₩186B₩186B₩246B₩227B₩123B₩113B₩113B
Total equity₩414B₩431B₩459B₩488B₩499B₩416B₩440B₩443B
Shareholders' equity₩61B₩141B₩158B₩158B₩143B₩149B₩159B₩123B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩9B−₩16B−₩17B−₩20B−₩13B₩17B−₩3.8B−₩24B
Capital spending₩743M₩458M₩1B₩898M₩1.2B₩3.5B₩12B−₩1.3B
Free cash flow−₩9.7B−₩17B−₩18B−₩21B−₩14B₩14B−₩16B−₩25B
Dividends paid——₩0—————

Consolidated where available. Amounts in won.

Also known as: Aprogen / 에이프로젠 / 007460 / KRX:007460

Source: KRX statistical information